Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ||||||||||
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -34.37%2.08M | 5.00%3.17M | -11.93%3.02M | 34.20%3.43M | -36.86%2.55M | 118.51%4.05M | 52.70%1.85M | 9.57%1.21M | -23.80%1.11M | -58.38%1.45M |
| Selling and administrative expenses | -45.56%1.4M | -16.27%2.57M | 31.09%3.07M | 726.95%2.34M | -78.09%283.25K | 21.66%1.29M | 9.89%1.06M | 21.48%966.88K | -15.35%795.92K | -41.17%940.28K |
| -Selling and marketing expense | ---- | ---- | -89.83%2.43K | --23.9K | ---- | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | -45.56%1.4M | -16.20%2.57M | 32.34%3.07M | 718.51%2.32M | -78.09%283.25K | 21.66%1.29M | 9.89%1.06M | 21.48%966.88K | -15.35%795.92K | -41.17%940.28K |
| Depreciation amortization depletion | -16.52%153.33K | 20.11%183.68K | 186.08%152.92K | 2,825.83%53.46K | -38.55%1.83K | -34.28%2.97K | -62.47%4.52K | 0.12%12.06K | -8.66%12.04K | -61.03%13.18K |
| -Depreciation and amortization | -16.52%153.33K | 20.11%183.68K | 186.08%152.92K | 2,825.83%53.46K | -38.55%1.83K | -34.28%2.97K | -62.47%4.52K | 0.12%12.06K | -8.66%12.04K | -61.03%13.18K |
| Other operating expenses | 27.04%527.45K | 303.00%415.2K | -119.81%-204.54K | -54.51%1.03M | -17.49%2.27M | 250.57%2.75M | 235.82%784.55K | -21.79%233.62K | -40.13%298.72K | -73.14%498.95K |
| Operating profit | 34.37%-2.08M | -5.00%-3.17M | 11.93%-3.02M | -34.20%-3.43M | 36.86%-2.55M | -118.51%-4.05M | -52.70%-1.85M | -9.57%-1.21M | 23.80%-1.11M | 58.38%-1.45M |
| Net non-operating interest income (expenses) | -52.45%28.11K | -14.32%59.13K | 2,198.80%69.01K | 3K | -41.62%3.62K | -64.10%6.2K | -71.89%17.26K | -53.36%61.4K | ||
| Non-operating interest income | -52.45%28.11K | -14.32%59.13K | 2,198.80%69.01K | --3K | ---- | ---- | -41.62%3.62K | -64.10%6.2K | -71.89%17.26K | -53.49%61.4K |
| Other net income (expenses) | 102.67%14.16K | -103.98%-529.62K | 178.11%13.31M | -102,642.05%-17.04M | 640.31%16.62K | 2.25K | -36.02%23.21K | 268.78%36.28K | -98.07%9.84K | |
| Other non-operating income (expenses) | 102.67%14.16K | -103.98%-529.62K | 178.11%13.31M | -102,642.05%-17.04M | 640.31%16.62K | --2.25K | ---- | -36.02%23.21K | 268.78%36.28K | -98.07%9.84K |
| Income before tax | 44.01%-2.04M | -135.13%-3.64M | 150.63%10.36M | -706.49%-20.47M | 37.24%-2.54M | -118.82%-4.04M | -56.19%-1.85M | -12.34%-1.18M | 23.75%-1.05M | 51.50%-1.38M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 44.01%-2.04M | -135.13%-3.64M | 150.63%10.36M | -706.49%-20.47M | 37.24%-2.54M | -118.82%-4.04M | -56.19%-1.85M | -12.34%-1.18M | 23.75%-1.05M | 51.50%-1.38M |
| Net income continuous operations | 44.01%-2.04M | -135.13%-3.64M | 150.63%10.36M | -706.49%-20.47M | 37.24%-2.54M | -118.82%-4.04M | -56.19%-1.85M | -12.34%-1.18M | 23.75%-1.05M | 51.50%-1.38M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 44.01%-2.04M | -135.13%-3.64M | 150.63%10.36M | -706.49%-20.47M | 37.24%-2.54M | -118.82%-4.04M | -56.19%-1.85M | -12.34%-1.18M | 23.75%-1.05M | 51.50%-1.38M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 44.01%-2.04M | -135.13%-3.64M | 150.63%10.36M | -706.49%-20.47M | 37.24%-2.54M | -118.82%-4.04M | -56.19%-1.85M | -12.34%-1.18M | 23.75%-1.05M | 51.50%-1.38M |
| Diluted earnings per share | ||||||||||
| Basic earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |